Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cutting-edge of advanced MRI for demyelinating diseases.
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
The Relationships Between Apathy and Executive Dysfunction in Multiple Sclerosis.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
Focal demyelinative damage and neighboring white matter integrity: an optic neuritis study.
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one - Time administration of encephalitogenic T cells.
Cost effectiveness of Sativex for spasticity in multiple sclerosis.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Multiple sclerosis: Response to vitamin D reduced in multiple sclerosis.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Changes of Synaptic Plasticity in Multiple Sclerosis.
Examining the relationships between cortical maturation and white matter myelination throughout early childhood.
Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
IMaGe: Iterative Multilevel Probabilistic Graphical Model for Detection and Segmentation of Multiple Sclerosis Lesions in Brain MRI.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Pages
« first
‹ previous
…
595
596
597
598
599
600
601
602
603
…
next ›
last »